Highlights and strategies of the EORTC Leukemia Group
Authors:
- 1 March 2002
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 38, 94-99
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDSBlood, 2001
- Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMAEuropean Journal of Cancer, 1999
- The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMABritish Journal of Haematology, 1998
- Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.Journal of Clinical Oncology, 1998
- New trends in the treatment of adult acute myeloid leukaemiaEuropean Journal of Cancer, 1997
- Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.Journal of Clinical Oncology, 1996
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- The value of BMT in AML patients in first remission A statistician's view-pointAnnals of Hematology, 1991
- On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.Journal of Clinical Oncology, 1989
- A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia: A leukemia-lymphoma group trial of the EORTCCancer, 1986